Enzyme pattern-directed chemotherapy. Effects of antipyrimidine combinations on the ribonucleotide content of hepatomas.
D015092:3-Deazauridine / Q000008:administration & dosage / Q000494:pharmacology* / Q000627:therapeutic use; D000818:Animals; D000903:Antibiotics, Antineoplastic / Q000008:administration & dosage / Q000494:pharmacology* / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D005688:Galactosamine / Q000008:administration & dosage / Q000494:pharmacology* / Q000627:therapeutic use; D066298:In Vitro Techniques; D008114:Liver Neoplasms, Experimental / Q000188:drug therapy* / Q000378:metabolism; D008297:Male; D009963:Orotic Acid / Q000494:pharmacology; D051381:Rats; D012263:Ribonucleosides / Q000008:administration & dosage / Q000494:pharmacology* / Q000627:therapeutic use; D012265:Ribonucleotides / Q000378:metabolism*; D014529:Uridine / Q000031:analogs & derivatives* / Q000494:pharmacology
D000903:Antibiotics, Antineoplastic; D012263:Ribonucleosides; D012265:Ribonucleotides; D015092:3-Deazauridine; D009963:Orotic Acid; D005688:Galactosamine; D014529:Uridine